Literature DB >> 2705544

Protein kinase inhibitor prevents pulmonary edema in response to H2O2.

A Johnson1, P Phillips, D Hocking, M F Tsan, T Ferro.   

Abstract

We investigated the effect of H2O2 (92 microM) in isolated guinea pig lungs perfused with a buffered Ringer solution. Pulmonary arterial pressure (Ppa), pulmonary capillary pressure (Ppc), and change in lung weight (delta W) were recorded at 0 min and at 15, 30, and 60 min after the H2O2. The capillary filtration coefficient (Kfc) was measured at 0 and 30 min. The perfusion of H2O2 increased the Ppa, Ppc, delta W, and Kfc. The thromboxane synthetase inhibitor Dazoxiben, or the vasodilator papaverine, prevented the increases in Ppa and Ppc. The protein kinase C (PKC) inhibitor H7 [1-(5-isoquinolinesulfonyl)-2-methylpiperazine dihydrochloride] prevented the increases in Ppa, Ppc, delta W, and Kfc, whereas the inactive isoquinoline HA1004 [N-(2-guanidinoethyl)-5-isoquinolinesulfonamide hydrochloride] had little effect on the H2O2 response. H2O2 increased the number of stress fibers and disrupted the peripheral band of cultured confluent endothelial cells, changes that were prevented with pretreatment with H7. PKC may mediate the increases in vascular permeability and pulmonary edema that occur in response to H2O2.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2705544     DOI: 10.1152/ajpheart.1989.256.4.H1012

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  14 in total

Review 1.  Reactive oxygen species in inflammation and tissue injury.

Authors:  Manish Mittal; Mohammad Rizwan Siddiqui; Khiem Tran; Sekhar P Reddy; Asrar B Malik
Journal:  Antioxid Redox Signal       Date:  2013-10-22       Impact factor: 8.401

2.  Different effects of low- and high-dose insulin on ROS production and VEGF expression in bovine retinal microvascular endothelial cells in the presence of high glucose.

Authors:  Haixiang Wu; Chunhui Jiang; Dekang Gan; Yujie Liao; Hui Ren; Zhongcui Sun; Meng Zhang; Gezhi Xu
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-04-15       Impact factor: 3.117

Review 3.  Regulation of endothelial permeability by Src kinase signaling: vascular leakage versus transcellular transport of drugs and macromolecules.

Authors:  Guochang Hu; Aaron T Place; Richard D Minshall
Journal:  Chem Biol Interact       Date:  2007-08-15       Impact factor: 5.192

Review 4.  ROS-activated calcium signaling mechanisms regulating endothelial barrier function.

Authors:  Anke Di; Dolly Mehta; Asrar B Malik
Journal:  Cell Calcium       Date:  2016-02-17       Impact factor: 6.817

5.  Rho and Reactive Oxygen Species at Crossroads of Endothelial Permeability and Inflammation.

Authors:  Pratap Karki; Konstantin G Birukov
Journal:  Antioxid Redox Signal       Date:  2019-06-28       Impact factor: 8.401

Review 6.  Role of H(2)O(2)-activated TRPM2 calcium channel in oxidant-induced endothelial injury.

Authors:  Claudie M Hecquet; Asrar B Malik
Journal:  Thromb Haemost       Date:  2009-04       Impact factor: 5.249

7.  Role of protein kinase C in oxidant--mediated activation of phospholipase A2 in rabbit pulmonary arterial smooth muscle cells.

Authors:  S Chakraborti; J R Michael
Journal:  Mol Cell Biochem       Date:  1993-05-12       Impact factor: 3.396

8.  Sustained pharmacological inhibition of deltaPKC protects against hypertensive encephalopathy through prevention of blood-brain barrier breakdown in rats.

Authors:  Xin Qi; Koichi Inagaki; Raymond A Sobel; Daria Mochly-Rosen
Journal:  J Clin Invest       Date:  2008-01       Impact factor: 14.808

9.  PKCdelta influences p190 phosphorylation and activity: events independent of PKCdelta-mediated regulation of endothelial cell stress fiber and focal adhesion formation and barrier function.

Authors:  Akua K Fordjour; Elizabeth O Harrington
Journal:  Biochim Biophys Acta       Date:  2009-07-23

10.  Direct activation of RhoA by reactive oxygen species requires a redox-sensitive motif.

Authors:  Amir Aghajanian; Erika S Wittchen; Sharon L Campbell; Keith Burridge
Journal:  PLoS One       Date:  2009-11-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.